256 related articles for article (PubMed ID: 33040078)
21. Impact of cancer-associated mutations in Hsh155/SF3b1 HEAT repeats 9-12 on pre-mRNA splicing in Saccharomyces cerevisiae.
Kaur H; Groubert B; Paulson JC; McMillan S; Hoskins AA
PLoS One; 2020; 15(4):e0229315. PubMed ID: 32320410
[TBL] [Abstract][Full Text] [Related]
22.
López-Oreja I; Gohr A; Playa-Albinyana H; Giró A; Arenas F; Higashi M; Tripathi R; López-Guerra M; Irimia M; Aymerich M; Valcárcel J; Bonnal S; Colomer D
Life Sci Alliance; 2023 Nov; 6(11):. PubMed ID: 37562845
[TBL] [Abstract][Full Text] [Related]
23. Pan-cancer analysis identifies mutations in
Liu Z; Zhang J; Sun Y; Perea-Chamblee TE; Manley JL; Rabadan R
Proc Natl Acad Sci U S A; 2020 May; 117(19):10305-10312. PubMed ID: 32332164
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the aberrant splicing of DVL2 induced by cancer-associated SF3B1 mutation.
Zhao B; Hu X; Zhou Y; Shi Y; Qian R; Wan Y
Biochem Biophys Res Commun; 2021 Mar; 546():21-28. PubMed ID: 33561744
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of SF3B1 by molecules targeting the spliceosome results in massive aberrant exon skipping.
Wu G; Fan L; Edmonson MN; Shaw T; Boggs K; Easton J; Rusch MC; Webb TR; Zhang J; Potter PM
RNA; 2018 Aug; 24(8):1056-1066. PubMed ID: 29844105
[TBL] [Abstract][Full Text] [Related]
26. SF3B1 is a stress-sensitive splicing factor that regulates both HSF1 concentration and activity.
Kim Guisbert KS; Guisbert E
PLoS One; 2017; 12(4):e0176382. PubMed ID: 28445500
[TBL] [Abstract][Full Text] [Related]
27. SF3B1 deficiency impairs human erythropoiesis via activation of p53 pathway: implications for understanding of ineffective erythropoiesis in MDS.
Huang Y; Hale J; Wang Y; Li W; Zhang S; Zhang J; Zhao H; Guo X; Liu J; Yan H; Yazdanbakhsh K; Huang G; Hillyer CD; Mohandas N; Chen L; Sun L; An X
J Hematol Oncol; 2018 Feb; 11(1):19. PubMed ID: 29433555
[TBL] [Abstract][Full Text] [Related]
28. Genetic alterations of SUGP1 mimic mutant-SF3B1 splice pattern in lung adenocarcinoma and other cancers.
Alsafadi S; Dayot S; Tarin M; Houy A; Bellanger D; Cornella M; Wassef M; Waterfall JJ; Lehnert E; Roman-Roman S; Stern MH; Popova T
Oncogene; 2021 Jan; 40(1):85-96. PubMed ID: 33057152
[TBL] [Abstract][Full Text] [Related]
29. SF3B1 mutation in pancreatic cancer contributes to aerobic glycolysis and tumor growth through a PP2A-c-Myc axis.
Yang JY; Huo YM; Yang MW; Shen Y; Liu DJ; Fu XL; Tao LY; He RZ; Zhang JF; Hua R; Jiang SH; Sun YW; Liu W
Mol Oncol; 2021 Nov; 15(11):3076-3090. PubMed ID: 33932092
[TBL] [Abstract][Full Text] [Related]
30. The splicing factor SNRPB promotes ovarian cancer progression through regulating aberrant exon skipping of POLA1 and BRCA2.
Li Y; Chen Z; Peng J; Yuan C; Yan S; Yang N; Li P; Kong B
Oncogene; 2023 Jul; 42(31):2386-2401. PubMed ID: 37391593
[TBL] [Abstract][Full Text] [Related]
31. Silencing Core Spliceosome Sm Gene Expression Induces a Cytotoxic Splicing Switch in the Proteasome Subunit Beta 3 mRNA in Non-Small Cell Lung Cancer Cells.
Blijlevens M; Komor MA; Sciarrillo R; Smit EF; Fijneman RJA; van Beusechem VW
Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32545483
[TBL] [Abstract][Full Text] [Related]
32. Targeting the splicing factor NONO inhibits GBM progression through GPX1 intron retention.
Wang X; Han M; Wang S; Sun Y; Zhao W; Xue Z; Liang X; Huang B; Li G; Chen A; Li X; Wang J
Theranostics; 2022; 12(12):5451-5469. PubMed ID: 35910786
[No Abstract] [Full Text] [Related]
33. The role of alternative splicing in cancer: From oncogenesis to drug resistance.
Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J
Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093
[TBL] [Abstract][Full Text] [Related]
34. Jerantinine A induces tumor-specific cell death through modulation of splicing factor 3b subunit 1 (SF3B1).
Chung FF; Tan PF; Raja VJ; Tan BS; Lim KH; Kam TS; Hii LW; Tan SH; See SJ; Tan YF; Wong LZ; Yam WK; Mai CW; Bradshaw TD; Leong CO
Sci Rep; 2017 Feb; 7():42504. PubMed ID: 28198434
[TBL] [Abstract][Full Text] [Related]
35. Interchangeable SF3B1 inhibitors interfere with pre-mRNA splicing at multiple stages.
Effenberger KA; Urabe VK; Prichard BE; Ghosh AK; Jurica MS
RNA; 2016 Mar; 22(3):350-9. PubMed ID: 26742993
[TBL] [Abstract][Full Text] [Related]
36. SNORA73B promotes endometrial cancer progression through targeting MIB1 and regulating host gene RCC1 alternative splicing.
Chen X; Li QH; Xie BM; Ji YM; Han Y; Zhao Y
J Cell Mol Med; 2023 Oct; 27(19):2890-2905. PubMed ID: 37488742
[TBL] [Abstract][Full Text] [Related]
37. Mutant SF3B1 promotes AKT- and NF-κB-driven mammary tumorigenesis.
Liu B; Liu Z; Chen S; Ki M; Erickson C; Reis-Filho JS; Durham BH; Chang Q; de Stanchina E; Sun Y; Rabadan R; Abdel-Wahab O; Chandarlapaty S
J Clin Invest; 2021 Jan; 131(1):. PubMed ID: 33031100
[TBL] [Abstract][Full Text] [Related]
38. Cancer-associated SF3B1 mutants recognize otherwise inaccessible cryptic 3' splice sites within RNA secondary structures.
Kesarwani AK; Ramirez O; Gupta AK; Yang X; Murthy T; Minella AC; Pillai MM
Oncogene; 2017 Feb; 36(8):1123-1133. PubMed ID: 27524419
[TBL] [Abstract][Full Text] [Related]
39. Copy-number and gene dependency analysis reveals partial copy loss of wild-type SF3B1 as a novel cancer vulnerability.
Paolella BR; Gibson WJ; Urbanski LM; Alberta JA; Zack TI; Bandopadhayay P; Nichols CA; Agarwalla PK; Brown MS; Lamothe R; Yu Y; Choi PS; Obeng EA; Heckl D; Wei G; Wang B; Tsherniak A; Vazquez F; Weir BA; Root DE; Cowley GS; Buhrlage SJ; Stiles CD; Ebert BL; Hahn WC; Reed R; Beroukhim R
Elife; 2017 Feb; 6():. PubMed ID: 28177281
[TBL] [Abstract][Full Text] [Related]
40. Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify.
Komor MA; Pham TV; Hiemstra AC; Piersma SR; Bolijn AS; Schelfhorst T; Delis-van Diemen PM; Tijssen M; Sebra RP; Ashby M; Meijer GA; Jimenez CR; Fijneman RJA
Mol Cell Proteomics; 2017 Oct; 16(10):1850-1863. PubMed ID: 28747380
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]